Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan.
The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan had …

Background The Liver Imaging Reporting and Data System (LI-RADS) CT and MRI
algorithm applies equally to CT, MRI with extracellular contrast agents (ECA-MRI), and MRI …

Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …

Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

Background: The present study aimed to systematically evaluate the diagnostic value of an
isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a …

Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel with …

Abstract Objectives The 8th International Forum for Liver Magnetic Resonance Imaging
(MRI), held in Basel, Switzerland, in October 2017, brought together clinical and academic …

Background Whether peritumoral dilation radiomics can excellently predict early
recrudescence (≤ 2 years) in hepatocellular carcinoma (HCC) remains unclear. Methods …

Background Hepatobiliary phase (HBP) hypointense nodules without arterial phase
hyperenhancement (APHE) at gadoxetic acid–enhanced MRI may indicate hepatocellular …